Athersys downgraded by B of A Securities with a new price target
$ATHX
Biotechnology: Pharmaceutical Preparations
Health Care
B of A Securities downgraded Athersys from Buy to Neutral and set a new price target of $1.25
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/19/2021 | $1.25 | Buy → Neutral | B of A Securities |
| 11/19/2021 | Buy → Neutral | BofA Securities |